The regulation of calcium homeostasis in T lymphocytes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Calcium nanoparticles target and activate T cells to enhance anti-tumor function.Nature communications · 2024
   Article
2. The role of TRPV1 in RA pathogenesis: worthy of attention.Frontiers in immunology · 2023
   Review
3. Characterisation of insomnia as an environmental risk factor for asthma via Mendelian randomization and gene environment interaction.Scientific reports · 2021
   Article
4. High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease.Frontiers in immunology · 2020
   Review
5. Inflammation, Cancer and Immunity-Implication of TRPV1 Channel.Frontiers in oncology · 2019
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as